Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines.
Venous thromboembolism (VTE) is an important cause of avoidable morbidity and mortality. However, routine prophylaxis for at-risk patients is underused. Recent guidelines issued by an international consensus group, including the International Union of Angiology (IUA), recommend use of low-molecular-weight heparins (LMWHs) for the treatment of acute VTE and prevention of recurrence, and for prophylaxis in surgical and medical patients. This review highlights current inadequacies in the provision of thromboprophylaxis, and considers the clinical implications of the European guidelines on the prevention and treatment of VTE.
Prandoni
Paolo
P
Department of Cardiothoracic and Vascular Sciences, Thromboembolism Unit, University of Padua, Italy. paoloprandoni@tin.it.
Thromb Haemost. 2005 Oct;94(4):750-9
16270626
Haemostasis. 1999 Nov-Dec;29(6):310-7
10844404
Thromb Haemost. 1999 Jan;81(1):22-5
10348714
Blood Coagul Fibrinolysis. 1998 Sep;9(6):499-505
9819000
Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001100
15495007
Arch Intern Med. 2000 Mar 27;160(6):809-15
10737280
Oncologist. 2003;8(4):381-8
12897335
N Engl J Med. 2005 Mar 10;352(10):969-77
15758007
Chest. 2008 Jun;133(6 Suppl):454S-545S
18574272
Onkologie. 2006 Oct;29(10):474-8
17028457
Ann Intern Med. 2004 Jun 1;140(11):867-73
15172900
J Clin Pathol. 1989 Feb;42(2):135-9
2921354
BMJ. 2003 Sep 13;327(7415):597-8
12969928
JAMA. 1993 Oct 13;270(14):1672
8411485
Arch Intern Med. 2005 Apr 11;165(7):733-8
15824291
N Engl J Med. 2004 May 27;350(22):2257-64
15163775
Ann Oncol. 2005 May;16 Suppl 4:iv136-139
15923414
Chest. 1995 Oct;108(4):978-81
7555172
Haematologica. 2005 Feb;90(2):220-4
15710575
J Thromb Haemost. 2003 Mar;1(3):425-32
12871445
Arch Intern Med. 1988 Jun;148(6):1425-6
3377625
Lancet. 2001 Jul 7;358(9275):9-15
11454370
Haematologica. 2006 Jan;91(1):64-70
16434372
J Intern Med. 2005 Apr;257(4):352-7
15788005
Haematologica. 2002 Jul;87(7):746-50; discussion 250
12091126
Thromb Haemost. 2005 Jan;93(1):76-9
15630494
Arch Intern Med. 2004 Jan 26;164(2):190-4
14744843
Ann Oncol. 2005 May;16(5):696-701
15802275
Haemostasis. 1994 Mar-Apr;24(2):128-31
7959360
Br J Surg. 2001 Jul;88(7):913-30
11442521
N Engl J Med. 2003 Oct 30;349(18):1695-702
14585937
Ann Intern Med. 1997 Mar 15;126(6):454-7
9072931
J R Soc Med. 1989 Apr;82(4):203-5
2716016
Chest. 2004 Sep;126(3 Suppl):401S-428S
15383479
Mayo Clin Proc. 1998 Sep;73(9):873-9
9737225
Int Angiol. 2006 Jun;25(2):101-61
16763532
Arch Intern Med. 2002 May 27;162(10):1144-8
12020185
Chest. 2000 Dec;118(6):1680-4
11115458
Ann Intern Med. 2007 Feb 6;146(3):211-22
17261856
N Engl J Med. 2003 Jul 10;349(2):146-53
12853587
Chest. 2008 Jun;133(6 Suppl):381S-453S
18574271
Semin Hematol. 2001 Apr;38(2 Suppl 5):12-9
11449339
Manag Care. 2006 Sep;15(9):49-50, 53-60, 66
17036939